Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans

Cytokine

Volumn 56, Issue 3, 2011, Pages 656-661

  Bostanci, N ^a   Akgul B ^b   Tsakanika, V ^c   Allaker, R P ^c   Hughes, F J ^d   McKay, I J ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF COLOGNE   (Germany)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aggregatibacter actinomycetemcomitants; Cytokines; Inflammation; Low dose doxycycline; Periodontal disease

Indexed keywords

DOXYCYCLINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; MONOCYTE; NONHUMAN; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; UPREGULATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; CELL LINE; CELL SURVIVAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; HUMANS; KINETICS; MONOCYTES; SUBCELLULAR FRACTIONS;

EID: 81455154384     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.08.039     Document Type: Article

References (57)

1. Haffajee A.D., Socransky S.S. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994, 5:78-111.
2. Marsh P.D. Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol 2005, 32(Suppl. 6):7-15.
3. Slots J., Listgarten M.A. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 1988, 15:85-93.
4. Haubek D. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis. APMIS 2010, (Suppl. 1):53.
5. Haffajee A.D., Torresyap G., Socransky S.S. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007, 34:243-253.
6. van Winkelhoff A.J., Rams T.E., Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996, 10:45-78.
7. Walker C., Preshaw P.M., Novak J., Hefti A.F., Bradshaw M., Powala C. Long-term treatment with sub-antimicrobial dose doxycycline has no antibacterial effect on intestinal flora. J Clin Periodontol 2005, 32:1163-1169.
8. Fine D.H., Kaplan J.B., Kachlany S.C., Schreiner H.C. How we got attached to Actinobacillus actinomycetemcomitans: A model for infectious diseases. Periodontol 2000 2006, 42:114-157.
9. Belibasakis G.N., Johansson A., Wang Y., Chen C., Kalfas S., Lerner U.H. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect Immun 2005, 73:342-351.
10. Belibasakis G.N., Johansson A., Wang Y., et al. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005, 30:56-63.
11. Fletcher J.M., Nair S.P., Ward J.M., Henderson B., Wilson M. Analysis of the effect of changing environmental conditions on the expression patterns of exported surface-associated proteins of the oral pathogen Actinobacillus actinomycetemcomitans. Microb Pathog 2001, 30:359-368.
12. van Winkelhoff A.J., Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 1999, 20:122-135.
13. Oscarsson J., Karched M., Thay B., Chen C., Asikainen S. Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells. BMC Microbiol 2008, 8:206.
14. Kelk P., Claesson R., Chen C., Sjostedt A., Johansson A. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int J Med Microbiol 2008, 298:529-541.
15. Bartova J., Krejsa O., Sirova M., Tlaskalova H., Prochazkova J., Duskova J. Local antibodies and cytokine responses in crevicular fluid of patients with juvenile periodontitis. Adv Exp Med Biol 1995, 371B:1109-1112.
16. Casarin R.C., et al. Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis. J Periodontal Res 2010, 45:635-642.
17. Silva N., Dutzan N., Hernandez M., et al. Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 2008, 35:206-214.
18. Nakamura T., Nitta H., Ishikawa I. Effect of low dose Actinobacillus actinomycetemcomitans lipopolysaccharide pretreatment on cytokine production by human whole blood. J Periodontal Res 2004, 39:129-135.
19. Fives-Taylor P.M., Meyer D.H., Mintz K.P., Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999, 20:136-167.
20. Henderson B., Wilson M., Sharp L., Ward J.M. Actinobacillus actinomycetemcomitans. J Med Microbiol 2002, 51:1013-1020.
21. Barksby H.E., Nile C.J., Jaedicke K.M., Taylor J.J., Preshaw P.M. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2009, 156:479-487.
22. Bostanci N., Allaker R., Johansson U., et al. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. Oral Microbiol Immunol 2007, 22:52-60.
23. Bostanci N., Allaker R.P., Belibasakis G.N., et al. Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 2007, 39:147-156.
24. Hamedi M., Belibasakis G.N., Cruchley A.T., Rangarajan M., Curtis M.A., Bostanci N. Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. Cytokine 2009, 45:99-104.
25. Graves D.T., Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003, 74:391-401.
26. Graves D.T., Delima A.J., Assuma R., Amar S., Oates T., Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998, 69:1419-1425.
27. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442.
28. Salvi G.E., Collins J.G., Yalda B., Arnold R.R., Lang N.P., Offenbacher S., et al. Alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997, 24:8-16.
29. Preshaw P.M., Hefti A.F., Bradshaw M.H. Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol 2005, 32:610-616.
30. Golub L.M., McNamara T.F., Ryan M.E., et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001, 28:146-156.
31. Gurkan A., Emingil G., Cinarcik S., Berdeli A. Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. Int J Dent Hyg 2008, 6:84-92.
32. Hanemaaijer R., Sorsa T., Konttinen Y.T., et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997, 272:31504-31509.
33. Hyc A., Osiecka-Iwan A., Niderla-Bielinska J., Moskalewski S. Influence of LPS, TNF, TGF-ss1 and IL-4 on the expression of MMPs, TIMPs and selected cytokines in rat synovial membranes incubated in vitro. Int J Mol Med 2011, 27:127-137.
34. Krakauer T., Buckley M. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother 2003, 47:3630-3633.
35. Shapira L., Barak V., Soskolne W.A., Halabi A., Stabholz A. Effects of tetracyclines on the pathologic activity of endotoxin: in vitro and in vivo studies. Adv Dent Res 1998, 12:119-122.
36. Emingil G., Gurkan A., Atilla G., Kantarci A. Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid. J Periodontol 2011, 82:452-461.
37. Gilbertson-Beadling S., Powers E.A., Stamp-Cole M., et al. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemother Pharmacol 1995, 36:418-424.
38. Mandell R.L., Tripodi L.S., Savitt E., Goodson J.M., Socransky S.S. The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Periodontol 1986, 57:94-99.
39. Cortelli S.C., Costa F.O., Kawai T., et al. Diminished treatment response of periodontally diseased patients infected with the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J Clin Microbiol 2009, 47:2018-2025.
40. Ziegler-Heitbrock H.W., Thiel E., Futterer A., Herzog V., Wirtz A., Riethmuller G. Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes. Int J Cancer 1988, 41:456-461.
41. Kornman K.S., Page R.C., Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997, 14:33-53.
42. Cazalis J., Bodet C., Gagnon G., Grenier D. Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models. J Periodontol 2008, 79:1762-1768.
43. Mpiga P., Mansour S., Morisset R., Beaulieu R., Ravaoarinoro M. Sustained interleukin-6 and interleukin-8 expression following infection with Chlamydia trachomatis serovar L2 in a HeLa/THP-1 cell co-culture model. Scand J Immunol 2006, 63:199-207.
44. Lavda M., Clausnitzer C.E., Walters J.D. Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid. J Periodontol 2004, 75:1663-1667.
45. Shapira L., Soskolne W.A., Houri Y., Barak V., Halabi A., Stabholz A. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun 1996, 64:825-828.
46. Uitto V.J., Firth J.D., Nip L., Golub L.M. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci 1994, 732:140-151.
47. Ma X., Sun J., Papasavvas E., et al. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J Immunol 2000, 164:1722-1729.
48. Ma X., Riemann H., Gri G., Trinchieri G. Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw 1998, 9:54-64.
49. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
50. Yucel O.O., Berker E., Gariboglu S., Otlu H. Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008, 35:365-370.
51. Tsai I.S., Tsai C.C., Ho Y.P., Ho K.Y., Wu Y.M., Hung C.C. Interleukin-12 and interleukin-16 in periodontal disease. Cytokine 2005, 31:34-40.
52. Fokkema S.J., Loos B.G., de Slegte C., et al. Increased release of IL-12p70 by monocytes after periodontal therapy. J Clin Periodontol 2003, 30:1091-1096.
53. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J Immunol 2008, 180:5771-5777.
54. Teles R., Sakellari D., Teles F., et al. Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota. J Periodontol 2010, 81:89-98.
55. Fujihashi K., Beagley K.W., Kono Y., et al. Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. Am J Pathol 1993, 142:1239-1250.
56. Akifusa S., Poole S., Lewthwaite J., Henderson B., Nair S.P. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 2001, 69:5925-5930.
57. Andrukhov O., Ulm C., Reischl H., Nguyen P.Q., Matejka M., Rausch-Fan X. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J Periodontol 2011, 82:885-892.